It’s been a while for an update, but Brad’s medical teams at NIH (National Institutes of Health) and here in New Orleans have been working to get approval for him to receive his immunotherapy infusions in NOLA. Due to COVID-19, travel is high risk and I’m happy to report that it’s approved! Brad will continue with the NIH clinical trial and receive his 2nd immunotherapy infusion tomorrow at the UMC Cancer center. That means no flying every 2 weeks to NIH 🙌🏻 (at least for now during COVID) . Brad’s doing really well considering all he has been through these last few months. Thank you for your continued prayers and support. We love you all. Stay safe and stay home! 😷